-
Jefferies Raises PT on Abiomed to $20
Monday, April 18, 2011 - 6:41am | 26Jefferies & Company has raised the price target on Abiomed (NASDAQ: ABMD) from $18 to $20 and maintains its Buy rating.
-
Merger Arbitrage Mondays – April 18, 2011
Monday, April 18, 2011 - 3:46am | 4815Merger activity remained steady last week with five new deals announced and five closing. You can find all the deals listed below in our Merger Arbitrage Tool that automatically updates itself during market hours. Deal Statistics: Total Number of Deals Closed in 2011 48 Total Number of Deals...
-
CryoLife Amends Tender Offer Related to its Proposed Acquisition of Cardiogenesis Corporation, To Acquire 49.9% (CRY)
Friday, April 15, 2011 - 4:36pm | 167CryoLife (NYSE: CRY) today announced it has amended its tender offer related to its proposed acquisition of Cardiogenesis Corporation to acquire only 49.9 percent of the outstanding shares of Cardiogenesis. On April 14, 2011, Cardiogenesis, CryoLife and CryoLife's wholly-owned subsidiary, CL...
-
10 Stocks Prime For Shorting
Friday, April 15, 2011 - 2:31pm | 226The screen below are for those stocks that have primarily been on a solid uptrend of late, but are starting to show signs of breaking down along with a loss of interest by the street as a whole. So if you are looking to short this recent market rally, use the list below as bit of a primer...
-
Active Screen - CANSLIM: Top 8 for April 15th
Friday, April 15, 2011 - 12:11pm | 1120For another week there was no change at the top (ranked by Market Cap): Apple (AAPL), Vale S.A. (VALE), Free McMoran (FCX), Barrick Gold (ABX), Baidu (BIDU), Research in Motion (RIMM), Cognizant Technlogy (CTSH), and Intuitive Surgical (ISRG). The Screener setup was as follows: Apple (AAPL) is...
-
Options Brief: Abiomed, Inc. (ABMD)
Friday, April 15, 2011 - 11:10am | 76Shares of Abiomed, Inc. (NASDAQ: ABMD) are higher on the session by 11.33%, trading at $16.79. Overall put volume is now running at 9.86x the daily average, with 38% of all puts traded being purchases on the offer. 2,475 contracts have traded on the session so far. Abiomed, Inc. is a provider of...
-
Top Percentage Gainers and Losers as of 10am 4/15/11 (AGO, OPXA, MBI, AMLN, ABMD, CTCT, CRUS, GGC, OTIV, SFG, BAC, LLY, ALKS)
Friday, April 15, 2011 - 10:09am | 317Best 1) Opexa Therapeutics (NASDAQ: OPXA): Trading up 24% from yesterday's close to $2.27. A positive report emanating from a clinical trial of its drug Tovaxin has shares up. 2) Assured Guaranty (NYSE: AGO): Trading up 18.84% from yesterday's close to $16.84. Bank of America (NYSE: BAC) has...
-
Jefferies Maintains Buy Rating, Adds $18 PT On ABMD
Friday, April 15, 2011 - 8:20am | 107Jefferies maintains its Buy rating and has added a price target of $18 on Abiomed Inc. (NASDAQ: ABMD), citing reimbursement risk. Says Jefferies, in the report, “NHIC's proposed local coverage determination effectively creates a reimbursement overhang on the stock. We continue to believe that the...
-
UPDATE: Piper Jaffray Raises PT on Gen-Probe to $78 (GPRO)
Friday, April 15, 2011 - 8:10am | 126Piper Jaffray is out with its report today on Gen-Probe (NASDAQ: GPRO), raising its PT from $69 to $78. In a note to clients, Piper Jaffray writes, "Our quarterly checks suggest improving CT/NG testing volumes, with surveyed accounts describing a 2.2% sequential volume increase. For comparative...
-
Wunderlich Securities Reports ABMD Company Update
Friday, April 15, 2011 - 8:01am | 109Wunderlich Securities has issued a report on the state of Abiomed Inc (NASDAQ: ABMD). Wunderlich writes, “A draft comment on the CMS website caused some renewed Impella reimbursement concerns, resulting in weakness in Abiomed (ABMD) shares Thursday. This local coverage decision proposal (for the...
-
Piper Jaffray Raises PT On Gen-Probe To $78
Friday, April 15, 2011 - 7:20am | 26Piper Jaffray has raised the price target on Gen-Probe (NASDAQ: GPRO) from $69 to $78 and maintains its Overweight rating.
-
Fast Money Picks For April 14th (LMT, RIMM, PBR, HOLX)
Thursday, April 14, 2011 - 8:02pm | 201On CNBC's Fast Money, Brian Kelly recommended Lockheed Martin Corporation (NYSE: LMT) as a buy. Lockheed Martin Corporation (LMT) fell 0.74% today, and it closed at $77.73. Guy Adami thinks that Research In Motion Limited (USA) (NASDAQ: RIMM) should be bought on Friday. Research In Motion Limited...
-
Defense is the Best Offense 04-14-2011
Thursday, April 14, 2011 - 6:35pm | 940Cusick's Corner You have heard the analogy, Defense is the best Offense, but did you think of that when you look at your portfolio. Oil and Metals have been moving this year but have definitely hit some resistance, especially with commodity inflation so prominent and expanding. This has put...
-
Options Brief: Baxter International Inc. (BAX)
Thursday, April 14, 2011 - 1:24pm | 95Shares of Baxter International Inc. (NYSE: BAX) are lower on the session by 1.14%, trading at $53.52. Overall put volume is now running at 4.64x the daily average, with 70% of all puts traded being purchases on the offer. 7,236 contracts have traded on the session so far. Baxter International...
-
Options Brief: Abiomed, Inc. (ABMD)
Thursday, April 14, 2011 - 11:30am | 102Shares of Abiomed, Inc. (NASDAQ: ABMD) are lower on the session by 4.85%, trading at $15.11. Overall put volume is now running at 9.44x the daily average, with 64% of all puts traded being purchases on the offer. 1,369 contracts have traded on the session so far. Abiomed, Inc. is a provider of...